Thus far (2016), there is no organism it doesn't work on (CRISPR has been used successfully on human cells, but not yet
in viable human embryos).
Our No. 2 story, on gene editing
in viable human embryos, reminds us of the many intricacies of human biology.
EMBRYO EDIT Researchers in China and Texas have used CRISPR / Cas9 to repair disease - causing mutations
in viable human embryos.
The first results of gene editing
in viable human embryos reveals it works better than we thought, but that there's another big problem blocking the way
Nearly five years after the gene - editing tool debuted, researchers for the first time have used it to alter genes
in viable human embryos.
Scientists reported selectively altering genes
in viable human embryos for the first time this year.
But, after researchers at Oregon Health and Science University managed to change the mutated version of the MYBPC3 gene to the unmutated version
in a viable human embryo last month, the predictable bioethical debate was reignited, and terms such as «Designer Babies» got thrown around a lot.
Not exact matches
But
in March, Lichun Tang of China's Beijing Proteome Research Center and colleagues reported using CRISPR / Cas9 to correct disease - causing mutations
in a small number of
viable human embryos.
There should be a complete ban on the implantation of a
human embryo created by the application of cloning technology into a womb, or any treatment of such a
human embryo intended to result
in its development into a
viable infant.
In July, researchers announced they had successfully edited the genome of viable human embryos with CRISPR; the technique allowed them to fix a disease - causing mutation in the embryos» DNA (though some are now skeptical of the researchers» results
In July, researchers announced they had successfully edited the genome of
viable human embryos with CRISPR; the technique allowed them to fix a disease - causing mutation
in the embryos» DNA (though some are now skeptical of the researchers» results
in the
embryos» DNA (though some are now skeptical of the researchers» results).
EDITS UNDER WAY Researchers
in Sweden have begun editing genes
in viable early
human embryos (four - cell stage, shown).
A 2017 experiment, also
in China, used CRISPR to edit DNA
in normal, presumably
viable fertilized eggs, or one - cell
human embryos.
In a step that some of the nation's leading scientists have long warned against and that has never before been accomplished, biologists in Oregon have edited the DNA of viable human embryos efficiently and apparently with few mistakes, according to a report in Technology Revie
In a step that some of the nation's leading scientists have long warned against and that has never before been accomplished, biologists
in Oregon have edited the DNA of viable human embryos efficiently and apparently with few mistakes, according to a report in Technology Revie
in Oregon have edited the DNA of
viable human embryos efficiently and apparently with few mistakes, according to a report
in Technology Revie
in Technology Review.
Today, biologists from Oregon report
in Nature that they have had unprecedented successes using that gene - editing technology to alter early - stage,
viable human embryos.
They've certainly been successful
in making their voices heard
in recent years — for example, over the question of what to do with the 400,000 frozen
human embryos left over from
in vitro fertilization with no
viable future.
This summer, scientists working
in a U.S. lab announced they'd used CRISPR to modify
viable human embryos, which were kept alive just a few days.
In April 2015, a different China - based team announced that they had modified a gene linked to a blood disease in human embryos (which were also not viable, and so could not have resulted in a live birth
In April 2015, a different China - based team announced that they had modified a gene linked to a blood disease
in human embryos (which were also not viable, and so could not have resulted in a live birth
in human embryos (which were also not
viable, and so could not have resulted
in a live birth
in a live birth).
Shoukhrat Mitalipov of Oregon Health and Science University led research
in which scientists edited the DNA of
viable human embryos.